Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration : A Randomized Phase 2 Trial
Citation
Liao , D S , Grossi , F V , El Mehdi , D , Gerber , M R , Brown , D M , Heier , J S , Wykoff , C C , Singerman , L J , Abraham , P , Grassmann , F , Nuernberg , P , Weber , B H F , Deschatelets , P , Kim , R Y , Chung , C Y , Ribeiro , R M , Hamdani , M , Rosenfeld , P J , Boyer , D S , Slakter , J S & Francois , C G 2020 , ' Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration : A Randomized Phase 2 Trial ' , Ophthalmology , vol. 127 , no. 2 , pp. 186-195 . https://doi.org/10.1016/j.ophtha.2019.07.011
Rights
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). Published by Elsevier Inc